The effect of carbidopa and benserazide on human plasma 5-hydroxytryptophan levels
暂无分享,去创建一个
[1] A. Carlsson,et al. Attempts to measure endogenous levels of dopa and 5-hydroxytryptophan in rat brain , 2005, Journal of Neural Transmission.
[2] F. Hirata,et al. Formation of 5-hydroxykynurenine and 5-hydroxykynurenamine from 5-hydroxytryptophan in rabbit small intestine. , 1979, Proceedings of the National Academy of Sciences of the United States of America.
[3] W. C. Purdy,et al. Liquid chromatographic-fluorometric system for the determination of indoles in physiological samples. , 1979, Analytical chemistry.
[4] G. Lees,et al. Inhibition of human and rat hepatic aminotransferase activity with L-3,4-dihydroxyphenylalanine by inhibitors of peripheral aromatic amino acid decarboxylase. , 1979, Molecular pharmacology.
[5] G. Johnson,et al. Radioenzymatic assay of DOPA (3,4-dihydroxyphenylalanine). , 1978, Clinical chemistry.
[6] S. Young,et al. A controlled study of tryptophan-benserazide in schizophrenia. , 1978, Communications in psychopharmacology.
[7] R. Wurtman,et al. Suppression of noradrenaline synthesis in sympathetic nerves by carbidopa, an inhibitor of peripheral dopa decarboxylase , 1977, Nature.
[8] H. Baker,et al. The determination of 5-hydroxytryptophan and its metabolites in plasma following administration to man. , 1976, Clinica chimica acta; international journal of clinical chemistry.
[9] J. Korf,et al. Serum levels of 5-hydroxyindole derivates after administration of L-5-hydroxytryptophan ethyl ester. , 1976, Research communications in chemical pathology and pharmacology.
[10] J. Warsh,et al. Brain and peripheral metabolism of 5-hydroxytryptophan-14C following peripheral decarboxylase inhibition. , 1976, The Journal of pharmacology and experimental therapeutics.
[11] J. Reid,et al. Transamination is a Major Pathway of L-Dopa Metabolism following Peripheral Decarboxylase Inhibition , 1974, Nature.